With generics horde advancing, Pfizer gives up Lipitor push

When Lipitor's first copycats were unleashed, Pfizer manned the battlements. With a combination of discounts, coupons and payer contracts, the drugmaker ($PFE) aimed to protect market share as long as…
Read the full story: News